| Revision as of 02:13, 10 May 2022 editFMSky (talk | contribs)Extended confirmed users, Pending changes reviewers222,403 edits Adding local short description: "American oncologist", overriding Wikidata description "distinguished professor" (Shortdesc helper)← Previous edit | Revision as of 02:14, 10 May 2022 edit undoFMSky (talk | contribs)Extended confirmed users, Pending changes reviewers222,403 editsNo edit summaryNext edit → | ||
| Line 26: | Line 26: | ||
| | children = | | children = | ||
| }} | }} | ||
| '''Lawrence Einhorn''' is an ] at ].<ref>{{Cite web | url=http://medicine.iupui.edu/HEMO/Faculty/viewHEMOFaculty.asp?facID=2697 | title=Indiana University, School of Medicine, Department of Medicine}}</ref> A pioneer in cancer treatment research, Einhorn developed ]-based chemotherapy regimens that increased cure rates while minimizing toxic side effects.<ref>{{cite news |author=<!--Staff writer(s); no by-line.--> |date=2018 |title=Marking a Milestone: Dr. Einhorn discovered testicular cancer cure 40 years ago |url=https://cancer.iu.edu/news-publications/Einhorn.shtml |work=Indiana University: News and Publications |access-date=10 Nov 2018 }}</ref><ref name="2005a">{{cite journal |date=2005 |title=An Interview With Lawrence Einhorn, MD: Testicular Cancer—Don't Settle for the Status Quo |journal=] |volume=1 |issue=4 |pages=67 |doi= 10.1200/JOP.2005.1.4.167|pmid= 20871701|pmc= 2794575}}</ref> | '''Lawrence Einhorn''' is an American ] at ].<ref>{{Cite web | url=http://medicine.iupui.edu/HEMO/Faculty/viewHEMOFaculty.asp?facID=2697 | title=Indiana University, School of Medicine, Department of Medicine}}</ref> A pioneer in cancer treatment research, Einhorn developed ]-based chemotherapy regimens that increased cure rates while minimizing toxic side effects.<ref>{{cite news |author=<!--Staff writer(s); no by-line.--> |date=2018 |title=Marking a Milestone: Dr. Einhorn discovered testicular cancer cure 40 years ago |url=https://cancer.iu.edu/news-publications/Einhorn.shtml |work=Indiana University: News and Publications |access-date=10 Nov 2018 }}</ref><ref name="2005a">{{cite journal |date=2005 |title=An Interview With Lawrence Einhorn, MD: Testicular Cancer—Don't Settle for the Status Quo |journal=] |volume=1 |issue=4 |pages=67 |doi= 10.1200/JOP.2005.1.4.167|pmid= 20871701|pmc= 2794575}}</ref> | ||
| ==Overview== | ==Overview== | ||
Revision as of 02:14, 10 May 2022
American oncologist| Lawrence Einhorn | |
|---|---|
| Alma mater | |
| Scientific career | |
| Institutions | |
Lawrence Einhorn is an American oncologist at Indiana University School of Medicine. A pioneer in cancer treatment research, Einhorn developed cisplatin-based chemotherapy regimens that increased cure rates while minimizing toxic side effects.
Overview
 | This section needs additional citations for verification. Please help improve this article by adding citations to reliable sources in this section. Unsourced material may be challenged and removed. (November 2018) (Learn how and when to remove this message) |
Einhorn received a B.S. from Indiana University in 1965 and his M.D. from the University of Iowa in 1968. He served his internship and residency at IU Medical Center, followed by a fellowship in Hematology/Oncology at the M.D. Anderson Hospital Tumor Institute in Houston, Texas. He returned to IU Medical Center in 1973 and was named Distinguished Professor of Medicine in 1987. He became the first Lance Armstrong Foundation Professor of Oncology in 2006.
Einhorn has received numerous honors in his career including the Glenn Irwin Experience Excellence Award, Riley Distinguished Lecturer, the Kettering Prize Cancer Research-General Motors Foundation, the ACCC Clinical Oncology Award, the Distinguished Clinician Award from the Milken Foundation, the Willis Stetson Award and Lecture from The University of Pennsylvania, the Richard and Hinda Rosenthal Foundation Award for Cancer Research, the Herman B Wells Visionary Award, the State of Israel Peace Medal, the Vermeil Medal of Paris, and The David A. Kamofsky Memorial Award and Lecture from the American Society of Clinical Oncology. He was elected to membership in the National Academy of Sciences and American Philosophical Society in 2001.
Famous patients
- Lance Armstrong – American cyclist. In 1996, Armstrong was battling stage three testicular cancer–that had spread to his brain, lungs, and abdomen. Dr. Einhorn led the medical team that treated Armstrong's cancer. By February 1997, Armstrong was declared cancer-free. The same year he founded the Livestrong Foundation, formerly known as the Lance Armstrong Foundation, to support cancer patients.
- Yuvraj Singh – Indian legendary cricket player, discovered cancer in his lungs during the 2011 Cricket World Cup. Singh was successfully treated for a mediastinal germ cell tumor (mediastinal seminoma). Returning to cricket after 1 year, Singh founded the YouWeCan Foundation which helped hundreds of cancer patients.
References
- "Indiana University, School of Medicine, Department of Medicine".
- "Marking a Milestone: Dr. Einhorn discovered testicular cancer cure 40 years ago". Indiana University: News and Publications. 2018. Retrieved 10 Nov 2018.
- ^ "An Interview With Lawrence Einhorn, MD: Testicular Cancer—Don't Settle for the Status Quo". Journal of Oncology Practice. 1 (4): 67. 2005. doi:10.1200/JOP.2005.1.4.167. PMC 2794575. PMID 20871701.
- ^ "How Einhorn Helped Turn a Deadly Cancer Into a Curable Disease". Oncology Live. 28 May 2014. Retrieved 10 Nov 2018.
- Lopresti, Mike (17 Jan 2013). "Lance Armstrong cancer doctor has no mixed feelings". USA Today. Retrieved 10 Nov 2018.
- Iver, Malathy (7 Feb 2012). "Yuvraj Singh's disease a model of curable cancer". The Times of India. Retrieved 10 Nov 2018.
- "Dr. Einhorn Treating Cricketer Yuvraj Singh for Germ Cell Tumor". CureTalk: Conversations about new treatments & cures. 9 Feb 2012. Retrieved 10 Nov 2018.
Authored works
- Einhorn, LH (2002). "Curing metastatic testicular cancer". Proc Natl Acad Sci U S A. 99 (7): 4592–5. doi:10.1073/pnas.072067999. PMC 123692. PMID 11904381.
- Einhorn, LH; Williams, SD (1980). "Chemotherapy of disseminated seminoma". Cancer Clin Trials. 3 (4): 307–13. PMID 6159120.